Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

First description of lipoptosis using IgM antibody SAM-6

July 7, 2004

Europe's CHMP hands down positive opinion for MabThera in indolent NHL

July 2, 2004

Effective cytolysis of Hodgkin's lymphoma tumor cells by antibody-cytokine fusion protein

July 2, 2004

First clinical trial of HER-2/neu-based vaccine in patients with breast and ovarian cancer

July 1, 2004

New phase II trial of MDX-070 in hormone refractory prostate cancer

June 29, 2004

SGN-15 and docetaxel combination promising in non-small cell lung cancer

June 29, 2004

Update on the antitumor efficacy of MDX-010

June 28, 2004

Panvac-VF enters phase III trial for pancreatic cancer

June 23, 2004

AMD-3100 improves the eligibility of MM patients for stem cell transplantation

June 23, 2004

FDA accepts Genmab IND for phase I/II study of HuMax-CD20 in CLL

June 22, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...